Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9281 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9216 |
High Similarity |
NPD1934 |
Approved |
0.9156 |
High Similarity |
NPD2801 |
Approved |
0.9038 |
High Similarity |
NPD3882 |
Suspended |
0.8816 |
High Similarity |
NPD1511 |
Approved |
0.8765 |
High Similarity |
NPD6166 |
Phase 2 |
0.8765 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8765 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD5494 |
Approved |
0.8701 |
High Similarity |
NPD1512 |
Approved |
0.8659 |
High Similarity |
NPD3818 |
Discontinued |
0.8636 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8625 |
High Similarity |
NPD7075 |
Discontinued |
0.8599 |
High Similarity |
NPD4380 |
Phase 2 |
0.8562 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8554 |
High Similarity |
NPD7074 |
Phase 3 |
0.8553 |
High Similarity |
NPD7819 |
Suspended |
0.8553 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8528 |
High Similarity |
NPD6232 |
Discontinued |
0.85 |
High Similarity |
NPD3817 |
Phase 2 |
0.8494 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8487 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8485 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8443 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8438 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8421 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8375 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8365 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8312 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8294 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8289 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8284 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8282 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8267 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8267 |
Intermediate Similarity |
NPD943 |
Approved |
0.8242 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8235 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8235 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8217 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8187 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8158 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8144 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8095 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.807 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8023 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD919 |
Approved |
0.8 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7952 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7922 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7912 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7911 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7898 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7885 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7885 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7881 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7826 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7826 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7826 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7821 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7744 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7742 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7742 |
Intermediate Similarity |
NPD447 |
Suspended |
0.773 |
Intermediate Similarity |
NPD920 |
Approved |
0.773 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7722 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7722 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7709 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7657 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7628 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7625 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7607 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7602 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7597 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7595 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7588 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7571 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7546 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7542 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7527 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.743 |
Intermediate Similarity |
NPD8312 |
Approved |
0.743 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7425 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7403 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD37 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7356 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7356 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7356 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7318 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7317 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7303 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7258 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7255 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7213 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7175 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7143 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7143 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7128 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7127 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7117 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7117 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7117 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7117 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7115 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7113 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7111 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7102 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7073 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7052 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7052 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7049 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7048 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7047 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7044 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7043 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7035 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7033 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7031
|
Intermediate Similarity |
NPD2493 |
Approved |